期刊文献+

吉西他滨的不良反应及其防治 被引量:29

原文传递
导出
摘要 吉西他滨是一种破坏细胞复制的二氟核苷类抗代谢药物,主要用于治疗局部进展性或转移性非小细胞肺癌和不能手术的晚期或转移性胰腺癌。吉西他滨的常见不良反应有骨髓抑制、胃肠道反应、流感样反应、水肿、过敏反应、肾毒性等。本文对其不良反应及防治予以介绍。
出处 《药物不良反应杂志》 2003年第3期176-177,共2页 Adverse Drug Reactions Journal
  • 相关文献

参考文献7

二级参考文献17

  • 1王肇炎.第13届亚太癌症会议内科肿瘤学的进展[J].中国肿瘤,1997,6(4):22-23. 被引量:3
  • 2Hoffman JP, Lipsitz S, Pisansky T, et al.Phase Ⅱ trial of preoperative radiation therapy and chemotherapy for patiens with localized, respectable adenocarcinoma of the pancreas:An Eastern Cooperative Oncology Group study[J].J Clin Oncol,1998,16(1):317-323.
  • 3Bremback FH, Schoppmeyer K, Leupold U, etal. A phase Ⅱpolit of 13-cisretinoic acid and interferon-αin patients with advanced pancreatic carcinoma[J].Cancer,1998,83(11);2317-2323.
  • 4Cullinan SA, Moertel CG, Fleming TR, et al. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma[J].JAMA,1985,253(4):2061-2067.
  • 5Buroker TR,O'Connell MJ, Wieand HJ, et al. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of davanced colorectal cancer[J].J Clin Oncol,1994,12(1):14-20.
  • 6Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial[J].J Clin Oncol,1997,15(6):2403-2413.
  • 7Stomiolo AM, Enas NH, Brown CA, et al. New drug gemcitabine treatment program for over 3000 patients with pancreas carcinoma[J].Cnacer,1999,85(6):1261-1268.
  • 8Manual H, Danial C,Luis PA, et al.Phase Ⅰ-Ⅱ study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer[J].J Clin Oncol,1999,17(2):585-592.
  • 9HertelLW,BoderGB,KroinJS,etal.Evaluationoftheantitumoractivityofgemcitabine(2′,2′-deoxycytidine)[J].CancerRes,1990,50(14):4417-4422.
  • 10BurrisJ,MooreMJ,AndersonJ,etal.Improvementsinsurvivalandclinicalbenefitwithgemcitabineasfirst-linetherapyforpatientswithadvancedpancreascancer:arandomizedtrial[J].JClinOncol,1997,15(6):2403-2413.

共引文献38

同被引文献200

引证文献29

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部